In the rifampicin group , the median increases ( vs day 1 ) on days 9 , 11 , and 15 were 4.1 - , 5.2 - , and 4.7-fold , respectively , for 6CR and 3.4 - , 4.1 - , and 4.7-fold , respectively , for 4HC .